Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership12,700 shares
Latest Disclosed Value $ 276,352
Deutsche Bank Ag\ ownership in SRPT / Sarepta Therapeutics, Inc.

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 12,700 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $276,352 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 11,990 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 5.92% during the quarter.

Deutsche Bank Ag\ has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 12,700 710 5.92 276 6.98 0.0000
2026-02-11 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 11,990 2,404 25.08 258 40.22 0.0001
2025-11-13 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 9,586 -124,492 -92.85 185 -91.97 0.0001
2025-08-12 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 134,078 -1,529,495 -91.94 2,293 -97.84 0.0008
2025-05-09 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,663,573 224 0.01 106,169 -47.51 0.0421
2025-06-30 2024-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 1,663,349 200,173 13.68 202,247 10.68 0.0792
2025-02-14 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,663,349 200,173 202,247 0.0789
2025-06-26 2024-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 1,463,176 -110,401 -7.02 182,736 -26.50 0.0744
2024-11-13 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,463,176 -110,401 182,736 0.0744
2025-06-12 2024-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 1,573,577 113,102 7.74 248,625 31.50 0.1122
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 1,573,577 113,102 248,625 0.1122
2025-06-02 2024-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 1,460,475 -14,487 -0.98 189,073 32.93 0.0878
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,460,475 -14,487 189,073 0.0878
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,474,962 403,844 37.70 142,231 9.54 0.0726
2023-11-24 2023-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 1,071,118 -35,584 -3.22 129,841 2.45 0.0838
2023-11-09 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,071,118 -35,584 129,841 0.0171
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 1,106,702 106,581 10.66 126,740 -8.06 0.0674
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,000,121 60,033 6.39 137,847 13.16 0.0768
2023-02-13 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 940,088 192,953 25.83 121,817 47.50 0.0701
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 747,135 59,042 8.58 82,588 60.12 0.0498
2022-08-11 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 688,093 -72,638 -9.55 51,579 -13.21 0.0288
2022-05-13 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 760,731 35,722 4.93 59,429 -8.97 0.0277
2022-02-16 2021-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 725,009 257,144 54.96 65,286 50.89 0.0294
2022-02-11 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 725,009 257,144 65,286 0.0032
2021-11-04 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 467,865 19,246 4.29 43,267 24.06 0.0205
2021-08-11 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 448,619 -61,096 -11.99 34,875 -8.20 0.0169
2021-05-13 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 509,715 -6,007 -1.16 37,989 -56.79 0.0205
2021-02-16 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 515,722 3,436 0.67 87,926 22.22 0.0537
2020-11-12 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 512,286 -215,366 -29.60 71,941 -38.34 0.0495
2020-08-13 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 727,652 -139,034 -16.04 116,671 37.62 0.0887
2020-05-14 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 866,686 -130,705 -13.10 84,780 -34.13 0.0757
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 997,391 156,416 18.60 128,700 103.19 0.0839
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 840,975 -89,249 -9.59 63,339 -55.19 0.0440
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 930,224 -108,076 -10.41 141,345 14.22 0.0830
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,038,300 -4,349 -0.42 123,751 8.76 0.0737
2019-04-01 2018-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 1,042,649 246,183 30.91 113,781 -11.55 0.0807
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,042,649 290,309 113,781
2021-12-21 2018-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 796,466 -122,998 -13.38 128,638 5.84 0.0650
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 752,340 -167,124 121,507 0.0840
2020-04-21 2018-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 919,464 -61,408 -6.26 121,535 67.24 0.0605
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 905,726 -75,146 119,715 79,514.4047
2019-10-23 2018-03-31 13F/A-2 SAREPTA THERAPEUTICS COM 803607100 980,872 -302,445 -23.57 72,671 1.78 0.0347
2019-10-18 2018-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 980,872 0 72,671 0.0347
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS COM 803607100 897,521 -385,796 66,495
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,283,317 -167,272 -11.53 71,401 8.52 0.0457
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,450,589 966,210 199.47 65,795 303.03 0.0451
2017-08-11 2017-06-30 13F SAREPTA THERAPEUTICS COM 803607100 484,379 221,219 84.06 16,325 109.64 0.0117
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS COM 803607100 263,160 -51,204 -16.29 7,787 -9.68 0.0058
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS COM 803607100 314,364 -17,766 -5.35 8,622 -57.72 0.0069
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS COM 803607100 332,130 -113,178 -25.42 20,394 140.21 0.0144
2016-08-15 2016-06-30 13F SAREPTA THERAPEUTICS COM 803607100 445,308 -215,057 -32.57 8,490 -34.12 0.0060
2016-05-16 2016-03-31 13F SAREPTA THERAPEUTICS COM 803607100 660,365 340,957 106.75 12,888 4.61 0.0097
2016-02-16 2015-12-31 13F SAREPTA THERAPEUTICS COM 803607100 319,408 7,018 2.25 12,320 22.84 0.0085
2015-11-17 2015-09-30 13F SAREPTA THERAPEUTICS COM 803607100 312,390 118,343 60.99 10,029 69.90 0.0078
2015-08-12 2015-06-30 13F SAREPTA THERAPEUTICS COM 803607100 194,047 -30,966 -13.76 5,903 97.76 0.0038
2015-05-15 2015-03-31 13F SAREPTA THERAPEUTICS COM 803607100 225,013 72,529 47.56 2,985 35.37 0.0019
2015-02-13 2014-12-31 13F SAREPTA THERAPEUTICS COM 803607100 152,484 71,025 87.19 2,205 28.50 0.0014
2014-11-14 2014-09-30 13F SAREPTA THERAPEUTICS COM 803607100 81,459 1,211 1.51 1,716 -28.17 0.0011
2014-08-15 2014-06-30 13F SAREPTA THERAPEUTICS COM 803607100 80,248 -19,566 -19.60 2,389 -0.29 0.0016
2014-05-15 2014-03-31 13F SAREPTA THERAPEUTICS COM 803607100 99,814 5,196 5.49 2,396 24.40 0.0017
2014-02-24 2013-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 94,618 -68,291 -41.92 1,926 -74.96 0.0014
2014-02-18 2013-12-31 13F SAREPTA THERAPEUTICS COM 803607100 94,618 1,926
2013-11-18 2013-09-30 13F SAREPTA THERAPEUTICS COM 803607100 162,909 15,359 10.41 7,692 37.11 0.0057
2013-08-16 2013-06-30 13F SAREPTA THERAPEUTICS COM 080360710 147,550 147,550 5,610 0.0046
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-10-23 2018-03-31 13F/A SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM Call 1,650 0.00 91 22.97 n/a n/a n/a
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS COM Call 1,650 0.00 74 34.55 n/a n/a n/a
2017-08-11 2017-06-30 13F SAREPTA THERAPEUTICS COM Call 1,650 0.00 55 14.58 n/a n/a n/a
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS COM Call 1,650 48 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-10-23 2018-03-31 13F/A SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM Put 179 9 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.